Hogar y Estilo de Vida
5 hábitos para añadir años a tu vida
Ver más
Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.003.037 | Novel Biomarkers In Risk Assessment And Management Of Cardiovascular Disease | Jan 20, 2025 | Jan 20, 2026 | Numerous lipid and non-lipid biomarkers have been proposed as potential risk markers for cardiovascular... | Ver |
| 11.003.038 | Biomarker Genes For Detection Of Lymph Node Metastases In Breast Cancer | May 15, 2019 | Policy Archived | As highlighted in a 2008 editorial, the ongoing difficulties with using molecular techniques to detect... | Ver |
| 11.003.039 | Pharmacogenomic And Metabolite Markers For Patients Treated With Thiopurines | Dec 20, 2024 | Dec 20, 2025 | The thiopurine class of drugs, which include azathioprine (a pro-drug for mercaptopurine), mercaptopurine,... | Ver |
| 11.003.040 | Genetic Testing For Alzheimer Disease | Nov 22, 2024 | Nov 20, 2025 | Alzheimer disease (ad) is the most common cause of dementia in elderly patients. for late-onset ad, there is... | Ver |
| 11.003.042 | Genetic Testing For Cardiac Ion Channelopathies | Feb 18, 2025 | Feb 20, 2026 | Genetic testing is available for patients suspected of having cardiac ion channelopathies, including long qt... | Ver |
| 11.003.046 | Genetic Testing For Fmr1 Variants (Including Fragile X Syndrome) | Feb 20, 2025 | Feb 20, 2026 | Fragile x syndrome (fxs) is the most common inherited form of mental disability and a known genetic cause of... | Ver |
| 11.003.047 | Gene Expression-Based Assays For Cancers Of Unknown Primary | Apr 15, 2024 | Apr 20, 2025 | Cancers of unknown primary represent 3% to 4% of cancers diagnosed in the united states. these cancers are... | Ver |
| 11.003.048 | Carrier Screening For Genetic Diseases | Oct 10, 2024 | Oct 20, 2025 | Carrier screening is performed to identify individuals at risk of having offspring with inherited recessive... | Ver |
| 11.003.049 | Genetic Testing For Diagnosis And Management Of Mental Health Conditions | Aug 20, 2024 | Aug 20, 2025 | Individual genes have been shown to be associated with the risk of psychiatric disorders and specific aspects... | Ver |
| 11.003.050 | Genetic Testing For Epilepsy | Mar 10, 2025 | Mar 20, 2026 | Epilepsy is a disorder characterized by unprovoked seizures. it is a heterogeneous condition that encompasses... | Ver |
| 11.003.051 | Gene Expression Profiling And Protein Biomarkers For Prostate Cancer Management | Oct 08, 2024 | Oct 20, 2025 | Gene expression profile analysis and protein biomarkers have been proposed as a means to risk-stratify... | Ver |
| 11.003.052 | Molecular Markers In Fine Needle Aspirates Of The Thyroid | Sep 24, 2024 | Sep 20, 2025 | To determine which patients need thyroid resection, many physicians will perform a cytologic examination of... | Ver |
| 11.003.053 | Whole Exome And Whole Genome Sequencing For Diagnosis Of Genetic Disorders | Apr 18, 2024 | Apr 20, 2025 | Whole exome sequencing (wes) sequences the portion of the genome that contains protein-coding dna, while... | Ver |
| 11.003.056 | Genetic Testing For A Thalassemia | Jul 10, 2024 | Jul 20, 2025 | Alpha-thalassemia represents a group of clinical syndromes of varying severity characterized by hemolytic... | Ver |
| 11.003.057 | Genetic Testing For Fanconi Anemia | Jan 15, 2025 | Jan 20, 2026 | Fanconi anemia (fa) is an inherited disorder characterized by congenital abnormalities, bone marrow failure,... | Ver |
| 11.003.059 | Genetic Testing For Hereditary Pancreatitis | Mar 10, 2025 | Mar 20, 2026 | ... | Ver |
| 11.003.060 | Genetic Testing For Flt3, Npm1, And Cebpa Variants In Cytogenetically Normal Acute Myeloid Leukemia | Feb 20, 2025 | Feb 20, 2026 | Treatment of acute myeloid leukemia (aml) is based on risk stratification, primarily related to patient age... | Ver |
| 11.003.062 | General Approach To Genetic Testing | Jan 21, 2025 | Jan 20, 2026 | Commercially available genetic tests can perform a host of functions, such as providing a guided intervention... | Ver |
| 11.003.063 | Bcr-Abl1 Testing In Chronic Myelogenous Leukjemia And Acute Lymphoblastic Leukemia | Dec 03, 2024 | Nov 20, 2025 | In the treatment of philadelphia chromosome-positive leukemias, various nucleic acid-based laboratory methods... | Ver |
| 11.003.064 | Genetic Cancer Susceptibility Panels Using Next Generation Sequencing | Dec 12, 2024 | Nov 20, 2025 | Commercially available cancer susceptibility gene panels can test for multiple variants associated with a... | Ver |
